The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Six LUDC researchers receive medicine and health grants from VR

Detail image from diabetes lab.
Six researchers at Lund University Diabetes Centre have been awarded research grants within medicine and health by the Swedish Research Council (VR). Photo: Kennet Ruona

We would like to congratulate six researchers at Lund University Diabetes Centre, who have been awarded research grants within medicine and health by the Swedish Research Council (VR).

The six researchers are affiliated with Excellence of Diabetes Research in Sweden (EXODIAB), which is a strategic research area within diabetes at Lund University.

  • Helena Elding Larsson, professor of autoimmune diseases, has been awarded SEK 5.4 million for a project which will investigate how diet and physical activity affects beta cell health and the development of diabetes-related autoantibodies in early childhood and whether autoimmunity during the first two years of life can be prevented through intervention.
     
  • Malin Fex, associate professor of metabolism, has been awarded a grant of SEK 3 million for studies of modeling of disease mechanisms in stem cells from patients with type 1 diabetes and monogenic diabetes (MODY).
     
  • Paul Franks, professor of genetic epidemiology, has been awarded a grant of SEK 3 million for studies into algorithms for precision health and medicine and how they can be utilised for evaluation of translational readiness in clinical environments.
     
  • Hindrik Mulder, professor of metabolism, has been awarded SEK 3 million for studies of disturbed metabolism in insulin-producing cells in diabetes using stem cells.
     
  • Marju Orho-Melander, professor of genetic epidemiology, has been awarded a grant of SEK 5.4 million. The project uses advanced methods to investigate the complex relationships between the gut microbiota, diet, genetics, liver fats, and type 2 diabetes through large prospective and longitudinal studies with repeated measurements.
     
  • Allan Vaag, professor of endocrinology, has been awarded SEK 5.4 million for his studies on pathophysiological and clinical aspects associated with the development of type 2 diabetes due to predominant adverse prenatal, genetic, or inferred postnatal lifestyle aetiologies. 

    Information about this year’s recipients of grants within medicine and health (vr.se)

 

Strategic research area

A significant part of diabetes research at Lund University is conducted within EXODIAB, which is a strategic research area (SRA) in Sweden.

Within EXODIAB, Lund University Diabetes Centre (LUDC) and Uppsala University work closely together. Their shared ambition is to develop new treatments and drugs that can prevent or cure diabetes.

Read more about EXODIAB (lunduniversity.lu.se)